Il Dong achieved 10.6% sales growth at 171.5 BW

Il Dong pharmaceutical company reported that during 2003 fiscal year ended at Mar. 31 2004 the comparative management performance over the previous year was 10.6% up of the sales growth at 171,500 million won, 8% up of the ordinary income at 23.3 billion won, 6.9% up of the net income at 14.1 billion won but 0.7% down of the operating income.

The debt ration turned down from 89,2% in 2002 t...